These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 999566)

  • 21. Gatifloxacin induced abnormalities in glucose homeostasis in a patient on glimepiride.
    Kesavadev J; Rasheed SA
    J Assoc Physicians India; 2006 Dec; 54():951-2. PubMed ID: 17334014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulphonylureas and cardiovascular disease: a problem for few diabetics.
    Slater SD; Ireland JT
    Scott Med J; 1979 Jan; 24(1):17-20. PubMed ID: 493926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oral antidiabetics of the sulfonylurea group and their problems in therapy].
    Füsgen I; Summa JD
    Z Gerontol; 1980; 13(1):45-51. PubMed ID: 7456613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and microscopic findings in the liver of patients with newly diagnosed diabetes and in diabetics treated with sulfonylurea derivatives].
    Mroszczyk M; Torzecka W; Torzecki Z; Pruszczyński M; Jurga-Waniek K
    Pol Tyg Lek; 1978 Feb; 33(7):253-5. PubMed ID: 634844
    [No Abstract]   [Full Text] [Related]  

  • 25. Blood coagulation in maturity--onset diabetics before and after treatment with glibenclamide.
    Bunnag SC; Israsena T; Watananukul P
    J Med Assoc Thai; 1972 Feb; 55(2):80-6. PubMed ID: 4622655
    [No Abstract]   [Full Text] [Related]  

  • 26. [High sensitivity to sulphonylurea treatment in 2 patients with maturity-onset diabetes of the young type 3].
    Bosselaar M; Hattersley AT; Tack CJ
    Ned Tijdschr Geneeskd; 2002 Apr; 146(15):726-9. PubMed ID: 11980375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical study with glypentide, new sulfonylurea hypoglycemic agent].
    Pou Torelló JM; Vilaclara JM
    Rev Iber Endocrinol; 1974; 21(125):427-30, 433-8, 441-2 passim. PubMed ID: 4608666
    [No Abstract]   [Full Text] [Related]  

  • 28. Glipizide evaluation after a one year trial in maturity onset diabetics.
    Dowey KE; Grant AP; Hayes JR
    Ulster Med J; 1979; 48(1):65-8. PubMed ID: 553357
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of diabetes mellitus with glibornurid].
    Vignati E; Liuzzi A; Chiodini PG
    Minerva Med; 1973 Oct; 64(75):3900-6. PubMed ID: 4767761
    [No Abstract]   [Full Text] [Related]  

  • 30. [Letter: Hypoglycemia following alcohol abuse in diabetic patients].
    Knick B
    Med Klin; 1973 Nov; 68(46):1524. PubMed ID: 4782870
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacology of antihyperglycemic drugs.
    Marble A
    N Y State J Med; 1972 Sep; 72(17):2174-8. PubMed ID: 4560042
    [No Abstract]   [Full Text] [Related]  

  • 32. [Role of octreotide in the treatment of hypoglycemia induced by sulfonylureas].
    Clerc D; Hugli O; Trueb L; Yersin B
    Rev Med Suisse; 2008 Aug; 4(167):1764-7. PubMed ID: 18800755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 34. [Behavior of lactate and pyruvate in diabetics treated with a combination of fenformin and sulfonylurea in varying doses. I].
    Lunetta M; Presti C; Mughini MT; Mughini L
    Clin Ter; 1980 Jun; 93(5):525-33. PubMed ID: 6775863
    [No Abstract]   [Full Text] [Related]  

  • 35. [Controversial aspects regarding metformin in type 2 diabetic patient: reduction of late complications in early, single drug administration; increased risk of death in later administration in combination with sulfonylurea compounds].
    Ritzmann P
    Praxis (Bern 1994); 1999 Aug; 88(33):1330-1. PubMed ID: 10483287
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypoglycemic adverse reactions to insulin and sulfonylureas.
    O'Donnell J
    Leg Med; 1993; ():193-232. PubMed ID: 8121229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diabetes mellitus and ischemic cardiopathy: potential effects of the use of sulfonylureas].
    Gonçalves JV; Caldeira J
    Rev Port Cardiol; 2001 Apr; 20(4):439-45. PubMed ID: 11433889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of HDL cholesterol in diabetes mellitus in relation to various types of therapy].
    Floriani M; Spadoni M
    Quad Sclavo Diagn; 1984 Jun; 20(2):236-43. PubMed ID: 6396678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of sulfonylurea agents in older diabetic patients.
    Peters AL; Davidson MB
    Clin Geriatr Med; 1990 Nov; 6(4):903-21. PubMed ID: 2224754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diabetes mellitus under 30 years of age. Results of 18 years experience with oral treatment (author's transl)].
    Mirouze J; Cartry E
    Diabete Metab; 1975 Jun; 1(2):113-8. PubMed ID: 1234068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.